Navigation Links
The Conference Forum Announces the Launch of Cell & Gene Therapy Day in NYC

The inaugural Cell & Gene Therapy Day takes place February 27, 2020 at the Crowne Plaza Times Square in New York City. The one-day event will be chaired by Dr Aiman Shalabi, VP R&D, Cell and Gene Therapies for GSK, with a diverse group of leaders in the space.

“We are witnessing significant innovation in cell and gene therapies, and we are at a turning point of advancing these technologies for solid tumors,” said Dr Shalabi. “This conference will engage global leaders on a series of scientific, investment landscape, regulatory and manufacturing topics with the ambition of accelerating these treatments to patients with solid cancers.”

Cell & Gene Therapy Day will focus primarily on the promising data and progress for solid tumors.
IO and cell therapy expert Dr Arie Belldegrun, Allogene, is the opening keynote and will kick off the day by addressing advancements in CAR-T cell therapy.

Immunotherapy expert, Dr Crystal Mackall, Director of the Stanford Center for Cancer Cell Therapy at Stanford University School of Medicine, will deliver a cornerstone presentation on new scientific frontiers in cell therapies for solid tumors. Dr Mackall has been a leader in treating hematologic tumors, with extensive work using CAR to target CD19 and CD22 in childhood leukemia.

The day will touch upon several different areas of cell and gene therapy. Dr Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration, will lead a panel on the evolution of regulatory policy for cell and gene therapy.

IO360 ° veteran Dr Ramy Ibrahim, Parker Institute for Cancer Immunotherapy, will address master protocols in cell and gene therapy, and his company’s own innovations in the field. Dr Ibrahim will also lead a discussion on the latest in collaborative development paradigms for cell therapies with Dr Elad Sharon, National Cancer Institute, and Dr Mitch Finer, ElevateBio.

Leaders from Loncor Investments, Cancer Research Institute, IQVIA and the Alliance for Regenerative Medicine will trace through the landscape and evolution of the cell and gene therapy marketplace.

One portion of the day will focus on pivotal developments in solid tumor treatment. The National Institutes of Health’s Dr Stephanie Goff will address tumor-infiltrating lymphocytes as a way of treating cancer. Dr Maria Fardis, Iovance, will speak on TILs as a way targeting individual tumor mutations. Dr Shalabi will return for an update on NY-ESO-1. Dr John Connolly, Tessa Therapeutics, will highlight the prognostic values of antiviral responses and using virus-specific T cells as a solid tumor immunotherapy platform. The day will conclude with debates on combinations with checkpoints, and bedside versus centralized manufacturing.

About Cell & Gene Therapy Day:
Cell & Gene Therapy Day convenes stakeholders spanning the science and business communities to report on the latest cell and gene therapy progress to fight a wider range of cancers beyond hematologic malignancies. Cell & Gene Therapy Day is available an independent one-day program with a luncheon and networking reception, or attendees can register for the three day IO360° program, which includes the Cell & Gene Therapy Day. For more information on IO360°, please click here.

About the Conference Forum:
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high-quality networking.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology news :

1. 2013 AAPS National Biotechnology Conference returns to San Diego
2. Oceanographer Sylvia Earle kicks off Northeasterns Sustaining Coastal Cities Conference
3. AAPS announces 2013 National Biotechnology Conference award winners
4. IAS 2013 conference program live online
5. Penn State to host pollinator health conference
6. NASP and ASCP Discuss Future of Specialty Pharmacy in Aging Market at Upcoming ASCP Conference
7. 21st European Biomass Conference and Exhibition
8. ENDO 2013 news conference and webcast schedule
9. IOF Worldwide Conference of Osteoporosis Patient Societies opens in Helsinki
10. Mount Sinai celebrates team science at second-annual SINAInnovations Conference Nov. 18-19, 2013
11. Albert Einstein College of Medicine hosts conference on Jewish genetic research
Post Your Comments:
(Date:11/12/2019)... ... November 12, 2019 , ... In’Tech Medical SAS ( ... creation of a Global Regulatory Affairs Department, to support Medical Device companies across ... regulatory element to any Medtech organization is more important than Research & Development, ...
(Date:11/12/2019)... ... November 12, 2019 , ... Atlantic ... purifiers, announced today that distributors voted their patented automatic and manual wipers the ... purifiers. , The most frequent maintenance task required of an ultraviolet water purifier ...
(Date:11/7/2019)... ... November 07, 2019 , ... R3 Stem Cell is now ... the rest of 2019. The code to use during checkout is FIFTYOFF and applies ... is the nation’s leader in regenerative therapies with over 12,000 successful stem cell procedures ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... ... ... Bold Brahim aka Jesse, a Spanish Arabian, was 11 years old when ... medical management, his condition worsened so his owner, Diane, sought a bone scan and ... had a severe injury to his deep digital flexor tendon in his right front ...
(Date:11/27/2019)... , ... November 25, 2019 , ... ... has announced the company’s first robotic-assisted and navigated surgery in the UK. The ... (NHS) by acclaimed spine surgeons, Dr. Syed Aftab and Dr. Alexander Montgomery. The ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... that they have been selected by Lantern Pharma to provided preclinical screening and ... obtain millions of data points using panels of unique and genetically edited cell ...
(Date:11/9/2019)... BOSTON (PRWEB) , ... November ... ... provider of artificial intelligence (AI)-powered technology for use in pathology research, today ... in liver biopsy samples from patients enrolled in the phase 3 selonsertib ...
Breaking Biology Technology: